Timothy Wilkin is an Infectious Disease physician affiliated with University of California System. OpenAlex indexes 165 publications with 5,852 citations (h-index 33); ClinicalTrials.gov lists 8 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4168 Front St
San Diego, CA 921032030
Telephone
800-926-8273Provider last certified this registry record 21 Jun 2024.
Clinical trials
- Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
Sponsor: University of California, San Diego
- CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
Sponsor: University of California, San Diego
- Study of Tecovirimat for Human Mpox Virus
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202534 payments$32,672openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202415 payments$10,079openpaymentsdata.cms.gov ↗
- ViiV Healthcare CompanyProgram year20246 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor100%Juluca100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2024–2026 per NIH RePORTER. The latest:
- UCSD Collaborative Clinical Trials Unit
University of California, San Diego
FY2026$3,265,806UM1AI069432 - Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)
University of California, San Diego
FY2026$87,368UG1CA275414
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer
New England Journal of Medicine
2022 - SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells
Nature Communications
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Eichenfield, MD
University of California System
Dean Ornish, MD
University of California System
Peter Fedullo, MD
University of California System
William Auger, MD
University of California System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”